Tumor Models 2018

DESCRIPTION

On 22 & 23 November 2018, Singapore will host the BioTech Pharma Summit: Tumor Models 2018 conference. This year’s event is bringing together industry and academic leaders from the preclinical and translational oncology community all over the World. Succeed in producing more predictive and clinically relevant preclinical research when developing your Immuno-Oncology therapies

Develop & Use More Sophisticated, Humanized & Clinically Relevant Models to Extract More Value from Preclinical Data Packages

We are witnessing the renaissance of the concept of immune-mediated cancer therapy, and the demand for predictive and robust preclinical models to minimize translational failures in immuno-oncology is at an all-time high. The need for leveraging phenotypic features of models and stimulating the response of immune system adds to the complexity of preclinical models and their applications.

A conference dedicated to advancing preclinical oncology for optimized translational & clinical success only at Tumor Models 2018

The BioTech Pharma Summit: Tumor Models 2018 is designed to feature and discuss cutting-edge complex immunocompetent models for cancer immunotherapy research as well as to present case studies of their successful applications. Check out advanced therapies through in vitro, in vivo and ex vivo models. All these and much more leading experts will discuss during two days of the summit.

KEY PRACTICAL LEARNING POINTS

  • Optimize Model Selection & Characterization
  • Advance Your Preclinical Predictions into the Clinic
  • Discover Valuable Clinical Data to Drive Your Preclinical & Translational Studies
  • Latest developments in preclinical to clinical translation
  • Tumor Models for Cancer Immunotherapy
  • Enhancing immune response
  • Methods of monitoring growth of T cells
  • Improved ways to oversee effectiveness of chemotherapy treatments
  • Latest developments in translational immuno-oncology
  • Preclinical tumor models for evaluating bispecific redirected T-Cell Therapeutics
  • Preclinical to clinical translation of anti-PD-1 blockade
  • Enhancing immune response
  • Human tumor xenograft efficacy models
  • Genetics and biology of tumors harboring ras mutations
  • 3D cell culture techniques for the tumor models
  • Advance therapies through innovative in vitro, in vivo and ex vivo models

WHO SHOULD ATTEND?

The BioTech Pharma Summit (EPM Group) are exclusive events designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors including:

  • Professors
  • Medical Oncologist
  • Director of Drug Discovery & Translational Research
  • Head of Oncology Research Unit
  • Research Investigator, Clinical Translational Oncology
  • Stem Cell & Regenerative Biology
  • Team Leader, Cell Biology
  • Modeling & Informatics
  • Associate Research Director
  • Chief of Hematology-Oncology
  • Oncology Team Leader
  • VP Head of IBU Immunotheraphy
  • Senior VP, Head of Immuno-oncology
  • Product Manager, Marketing
  • Molecular Histopathology
  • Tumor Cell Biology & Oncology
  • Head, Biology & Translational Pharmacology
  • Head Search & Evaluation Neuroscience
  • Principal Research Scientist
  • Head, Business Development
  • Engineering and Biologics Design
  • Manager Disease Models
  • VP Immune Monitoring
  • Genome Editing
Basic Package
1,995
Buy Ticket

Access to all Sessions

Access to all Networking Sessions

Cocktail Reception Included

Premium Package
3,550
Buy Ticket

Unique one-on-one meetings

Airport pick-up/drop-off

2 nights at the Hotel Venue

Basic Exhibition Package
3,550
Buy Ticket

3m2 exhibition space

1 Complementary ticket

25% discount for extra ticket

Premium Exhibition Package
6,995
Buy Ticket

6m2 exhibition space

1 Complementary ticket

2 nights at the Hotel Venue